Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2009

Open Access 01-12-2009 | Case report

Successful renal re-transplantation in the presence of pre-existing anti-DQ5 antibodies when there was zero mismatch at class I human leukocyte antigen A, B, & C: a case report

Authors: John Hartono, Bhavna Lavingia, Peter Stastny, Martin Senitko, Miguel Vazquez, Juan Arenas, Christopher Lu

Published in: Journal of Medical Case Reports | Issue 1/2009

Login to get access

Abstract

Introduction

Hyperacute rejection may be prevented by avoiding the transplantation of kidneys into patients with pre-existing anti-donor Class I human leukocyte antigen antibodies. However, the role of anti-donor-Class II-human leukocyte antigen-DQ antibodies is not established. The question is ever more relevant as more sensitive cross-matching techniques detect many additional antibodies during the final crossmatch. We now report successful renal transplantation of a patient who had pre-existing antibodies against his donor's human leukocyte antigen-DQ5.

Case presentation

Our patient, a Caucasian man, was 34 years of age when he received his first deceased donor renal transplant. After 8 years, his first transplant failed from chronic allograft dysfunction and an earlier bout of Banff 1A cellular rejection. The second deceased donor kidney transplant was initially allocated to the patient due to a 0 out of 6 mismatch. The B cell crossmatch was mildly positive, while the T Cell crossmatch was negative. Subsequent assays showed that the patient had preformed antibodies for human leukocyte antigen DQ5 against his second donor. Despite having preformed antibodies against the donor, the patient continues to have excellent allograft function two years after his second renal transplant.

Conclusion

The presence of pre-existing antibodies against human leukocyte antigen DQ5 does not preclude transplantation. The relevance of having other antibodies against class II human leukocyte antigens prior to transplantation remains to be studied.
Appendix
Available only for authorised users
Literature
1.
go back to reference Patel R, Terasaki PI: Significance of the positive crossmatch test in kidney transplantation. N Engl J Med. 1969, 280: 735-739.CrossRefPubMed Patel R, Terasaki PI: Significance of the positive crossmatch test in kidney transplantation. N Engl J Med. 1969, 280: 735-739.CrossRefPubMed
2.
go back to reference Susal C, Opelz G: Kidney graft failure and presensitization against HLA class I and class II antigens. Transplant. 2002, 73: 1269-1273. 10.1097/00007890-200204270-00014.CrossRef Susal C, Opelz G: Kidney graft failure and presensitization against HLA class I and class II antigens. Transplant. 2002, 73: 1269-1273. 10.1097/00007890-200204270-00014.CrossRef
3.
go back to reference Gebel HM, Bray RA, Nickerson P: Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk. Am J Transplant. 2003, 3: 1488-1500. 10.1046/j.1600-6135.2003.00273.x.CrossRefPubMed Gebel HM, Bray RA, Nickerson P: Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk. Am J Transplant. 2003, 3: 1488-1500. 10.1046/j.1600-6135.2003.00273.x.CrossRefPubMed
4.
go back to reference Leffell MS, Montgomery RA, Zachary AA: The changing role of antibody testing in transplantation. Clin Transpl. 2005, 259-271. Leffell MS, Montgomery RA, Zachary AA: The changing role of antibody testing in transplantation. Clin Transpl. 2005, 259-271.
5.
go back to reference Freedman BI, Thacker LR, Heise ER, Adams PL: HLA-DQ matching in cadaveric renal transplantation. Clin Transplant. 1997, 11: 480-484.PubMed Freedman BI, Thacker LR, Heise ER, Adams PL: HLA-DQ matching in cadaveric renal transplantation. Clin Transplant. 1997, 11: 480-484.PubMed
6.
go back to reference Iniotaki-Theodoraki AG, Boletis JN, Trigas G, Kalogeropoulou HG, Kostakis AG, Stavropoulos-Giokas CG: Humoral immune reactivity against human leukocyte antigen (HLA)-DQ graft molecules in the early posttransplantation period. Transplantation. 2003, 75: 1601-1603. 10.1097/01.TP.0000061611.51612.09.CrossRefPubMed Iniotaki-Theodoraki AG, Boletis JN, Trigas G, Kalogeropoulou HG, Kostakis AG, Stavropoulos-Giokas CG: Humoral immune reactivity against human leukocyte antigen (HLA)-DQ graft molecules in the early posttransplantation period. Transplantation. 2003, 75: 1601-1603. 10.1097/01.TP.0000061611.51612.09.CrossRefPubMed
7.
go back to reference Worthington JE, Martin S, Al Husseini DM, Dyer PA, Johnson RW: Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome. Transplant. 2003, 75: 1034-1040. 10.1097/01.TP.0000055833.65192.3B.CrossRef Worthington JE, Martin S, Al Husseini DM, Dyer PA, Johnson RW: Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome. Transplant. 2003, 75: 1034-1040. 10.1097/01.TP.0000055833.65192.3B.CrossRef
8.
go back to reference Muczynski KA, Cotner T, Anderson SK: Unusual expression of human lymphocyte antigen class II in normal renal microvascular endothelium. Kidney International. 2001, 59: 488-497. 10.1046/j.1523-1755.2001.059002488.x.CrossRefPubMed Muczynski KA, Cotner T, Anderson SK: Unusual expression of human lymphocyte antigen class II in normal renal microvascular endothelium. Kidney International. 2001, 59: 488-497. 10.1046/j.1523-1755.2001.059002488.x.CrossRefPubMed
9.
go back to reference Zachary AA, Montgomery RA, Jordan SC, Reinsmoen NL, Claas FH, Reed EF: 14th International HLA and Immunogenetics Workshop: report on understanding antibodies in transplantation. Tissue Antigens. 2007, 69 (1): 160-173. 10.1111/j.1399-0039.2006.00764.x.CrossRefPubMed Zachary AA, Montgomery RA, Jordan SC, Reinsmoen NL, Claas FH, Reed EF: 14th International HLA and Immunogenetics Workshop: report on understanding antibodies in transplantation. Tissue Antigens. 2007, 69 (1): 160-173. 10.1111/j.1399-0039.2006.00764.x.CrossRefPubMed
10.
go back to reference Egbuna O, Zand MS, Arbini A, Menegus M, Taylor J: A cluster of parvovirus B19 infections in renal transplant recipients: a prospective case series and review of the literature. Am J Transplant. 2006, 6: 225-231. 10.1111/j.1600-6143.2005.01139.x.CrossRefPubMed Egbuna O, Zand MS, Arbini A, Menegus M, Taylor J: A cluster of parvovirus B19 infections in renal transplant recipients: a prospective case series and review of the literature. Am J Transplant. 2006, 6: 225-231. 10.1111/j.1600-6143.2005.01139.x.CrossRefPubMed
11.
go back to reference Sun Q, Liu ZH, Cheng Z, Chen J, Ji S, Zeng C, Li LS: Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil. Kidney Int. 2007, 71: 24-30. 10.1038/sj.ki.5001870.CrossRefPubMed Sun Q, Liu ZH, Cheng Z, Chen J, Ji S, Zeng C, Li LS: Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil. Kidney Int. 2007, 71: 24-30. 10.1038/sj.ki.5001870.CrossRefPubMed
12.
go back to reference Nickeleit V, Andreoni K: The classification and treatment of antibody-mediated renal allograft injury: where do we stand?. Kidney Int. 2007, 71: 7-11. 10.1038/sj.ki.5002003.CrossRefPubMed Nickeleit V, Andreoni K: The classification and treatment of antibody-mediated renal allograft injury: where do we stand?. Kidney Int. 2007, 71: 7-11. 10.1038/sj.ki.5002003.CrossRefPubMed
Metadata
Title
Successful renal re-transplantation in the presence of pre-existing anti-DQ5 antibodies when there was zero mismatch at class I human leukocyte antigen A, B, & C: a case report
Authors
John Hartono
Bhavna Lavingia
Peter Stastny
Martin Senitko
Miguel Vazquez
Juan Arenas
Christopher Lu
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2009
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/1752-1947-3-41

Other articles of this Issue 1/2009

Journal of Medical Case Reports 1/2009 Go to the issue